Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02924194 · ClinicalTrials.gov registry record · NA
Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
A NA study, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02924194: Clinical Trial NA study, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
NCT02924194 is a NA study that was terminated before completion, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02924194, a NA study, was terminated before completion, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of deep brain stimulation of the nucleus basalis of Meynert (also called the "nbM") at improving memory in Parkinson's disease patients with mild cognitive impairments and memory difficulties. Patients with Parkinson's disease (PD) that are eligible for Deep Brain Stimulation (DBS) therapy for improvement of their motor symptoms and with evidence of mild cognitive impairments and memory difficulties will be enrolled.
Primary Outcome
Evaluate safety through collection of adverse events at weeks 4, 16, 28, 52 and months 24 and 36.
Interventions
- DEVICE stimulation ON
- DEVICE stimulation OFF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-09 |
| Est. Completion | 2021-04-15 |
| Phase | NA |
Why NCT02924194 stopped before completion
NCT02924194 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which stimulation ON is the first listed.
NCT02924194 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02924194 about?
NCT02924194 is a clinical study titled "Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease". The purpose of this study is to evaluate the safety and effectiveness of deep brain stimulation of the nucleus basalis of Meynert (also called the "nbM") at improving memory in Parkinson's disease patients with mild cognitive impairments and memory difficulties. Patients with Parkinson's disease (PD...
What is the current status of trial NCT02924194?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2016-09. Estimated completion is 2021-04-15.
What interventions are being tested in trial NCT02924194?
The interventions under investigation include: stimulation ON (DEVICE), stimulation OFF (DEVICE).
Who is sponsoring clinical trial NCT02924194?
This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02924194's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia